Legal Representation
Attorney
Lawrence Apolzon
USPTO Deadlines
Next Deadline
1824 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-30)
Due Date
July 30, 2030
Grace Period Ends
January 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 15, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jan 28, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jan 28, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Oct 30, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 30, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 30, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 14, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 5, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 28, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 27, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 17, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 27, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 27, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 9, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 30, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 26, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 25, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals for use in product development in the fields of science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use
Class 005
Pharmaceutical preparations for targeting of disordered proteins; chemical, analytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-related, neurological and neurodegenerative diseases
Class 040
Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals
Class 042
Scientific, medical, and medical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaid, including such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals, and gene therapies; medical and scientific research, namely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological research, clinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences
Classification
International Classes
001
005
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
THERAPEUTICS